Results 141 to 150 of about 11,689 (208)

[Characteristics of the reactogenic poperties of parapertussis vaccine].

Zhurnal mikrobiologii, epidemiologii i immunobiologii, 1969
M S, Zakharova, A K, Men'shikova, K A, Vasil'eva, A I, Vorob'eva   +3 more
openaire   +1 more source

SARS-CoV-2 and Influenza Co-Circulation and Co-Vaccination: A Narrative Review. [PDF]

Vaccines (Basel)
Kamransarkandi M, Varyushina EA, Gorshkov AN, Stukova MA.   +3 more
europepmc   +1 more source

[Criteria for the assessment of the reactogenicity of ADPT vaccine].

Zhurnal mikrobiologii, epidemiologii i immunobiologii, 1974
M S, Zakharova, O M, Novikova, D S, Selidovkin, V Ia, Kokina, V I, Lebedeva   +4 more
openaire   +1 more source

Safety of sinopharm COVID-19 vaccine in children and adolescents aged 5 to 18 years: a cohort event monitoring study. [PDF]

BMC Public Health
Emamian MH, Sahab-Negah S, Nili S, Mangolian Shahrbabaki P, Ansari-Moghaddam A, Fereidouni M, Enayatrad M, Mahdavi S, Aliyari R, Fateh M, Khajeha H, Emamian Z, Behmanesh E, Sharifi H.   +13 more
europepmc   +1 more source

[The reactogenicity of dried oral typhoid vaccine].

Zhurnal mikrobiologii, epidemiologii i immunobiologii, 1971
A N, Meshalova, V I, Faĭn, A A, Kompaniets, V N, Drozdov, V D, Balaian   +4 more
openaire   +1 more source

An inflammation-defying adjuvant "micro"manages age-diminished vaccine efficacy. [PDF]

Mol Ther Nucleic Acids
Liu G.
europepmc   +1 more source

Low reactogenicity and high tumour antigen expression from mRNA-LNPs with membrane-destabilizing zwitterionic lipids. [PDF]

Nat Biomed Eng
Zhao Y, Li R, Liu P, Wang J, Cui Y, Ma Y, Cao Z, Cui M, Luozhong S, Wagner E, Laflin A, Ding Y, Hu Y, Tian Z, Tang C, Cai S, Young H, Liu D, Gu W, Bailey S, Jiang S.   +20 more
europepmc   +1 more source

The safety, reactogenicity, and immunogenicity of the self-amplifying mRNA COVID-19 vaccine GRT-R910 as a booster in healthy adults. [PDF]

Vaccine
Whitaker JA, Rebolledo PA, Abate G, Babu TM, Rouphael NG, Wald A, El Sahly HM, Jooss K, Hart MG, Makowski M, Mu J, Carmack A, Archer JI, Roberts PC, Makhene M, Posavad CM, McElrath MJ, De Rosa SC, Coler R, Montefiori D, Eaton A, Suthar MS, Atmar RL, Hoft DF, DMID 20-0034 Study Team.   +24 more
europepmc   +1 more source

[Laboratory markers of the reactogenicity of smallpox vaccines].

Voprosy virusologii, 1972
S S, Marennikova, I A, Svet-Moldavskaia, N M, Mal'tseva   +2 more
openaire   +1 more source

A phase 1, single-center, randomized, dose finding study to evaluate the safety, tolerability, and immunogenicity of a prophylactic COVID-19 pDNA vaccine after single ascending doses in healthy adults. [PDF]

Front Med (Lausanne)
Almansour-Alzamil I.
europepmc   +1 more source